| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy
|
Lipworth, Brian
|
|
|
10 |
1 |
p. e7
|
article
|
| 2 |
Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy – Authors' reply
|
Menzies-Gow, Andrew
|
|
|
10 |
1 |
p. e8
|
article
|
| 3 |
Advancing precision medicine for acute respiratory distress syndrome
|
Beitler, Jeremy R
|
|
|
10 |
1 |
p. 107-120
|
article
|
| 4 |
Authors' reply
|
Naccache, Jean-Marc
|
|
|
10 |
1 |
p. e4
|
article
|
| 5 |
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
|
Kawashima, Yosuke
|
|
|
10 |
1 |
p. 72-82
|
article
|
| 6 |
Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies
|
Allinson, James P
|
|
|
10 |
1 |
p. 83-94
|
article
|
| 7 |
Changes in rates of prescriptions for inhaled corticosteroids during the COVID-19 pandemic
|
Crook, Joanne
|
|
|
10 |
1 |
p. 6-7
|
article
|
| 8 |
Correction to Lancet Respir Med 2021; 9: 1275–87
|
|
|
|
10 |
1 |
p. e9
|
article
|
| 9 |
Correction to Lancet Respir Med 2021; 9: e116–17
|
|
|
|
10 |
1 |
p. e9
|
article
|
| 10 |
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Naccache, Jean-Marc
|
|
|
10 |
1 |
p. 26-34
|
article
|
| 11 |
Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter?
|
Amin-Chowdhury, Zahin
|
|
|
10 |
1 |
p. e1-e2
|
article
|
| 12 |
Heterogeneity of IPF exacerbations
|
Ramakrishnan, Sanjay
|
|
|
10 |
1 |
p. e3
|
article
|
| 13 |
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
|
Wechsler, Michael E
|
|
|
10 |
1 |
p. 11-25
|
article
|
| 14 |
Middle airway obstruction: phenotyping vocal cord dysfunction or inducible laryngeal obstructions
|
Leong, Paul
|
|
|
10 |
1 |
p. 3-5
|
article
|
| 15 |
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
|
Menzies-Gow, Andrew
|
|
|
10 |
1 |
p. 47-58
|
article
|
| 16 |
“Phasedown” of coal use after COP26 negotiations
|
Burki, Talha Khan
|
|
|
10 |
1 |
p. 10
|
article
|
| 17 |
Placing the patient's voice centre stage in 2022
|
The Lancet Respiratory Medicine,
|
|
|
10 |
1 |
p. 1
|
article
|
| 18 |
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19
|
Milross, Luke
|
|
|
10 |
1 |
p. 95-106
|
article
|
| 19 |
Prescription for e-cigs in the UK
|
Kirby, Tony
|
|
|
10 |
1 |
p. e10
|
article
|
| 20 |
Restricted spirometry through the lifespan
|
Mannino, David M
|
|
|
10 |
1 |
p. 2-3
|
article
|
| 21 |
Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial
|
Rosenkranz, Stephan
|
|
|
10 |
1 |
p. 35-46
|
article
|
| 22 |
Stargazing
|
Harris, Erica
|
|
|
10 |
1 |
p. 7-9
|
article
|
| 23 |
The role of growth and nutrition in the early origins of spirometric restriction in adult life: a longitudinal, multicohort, population-based study
|
Voraphani, Nipasiri
|
|
|
10 |
1 |
p. 59-71
|
article
|
| 24 |
Tolerability and impact of SARS-CoV-2 vaccination in elite athletes
|
Hull, James H
|
|
|
10 |
1 |
p. e5-e6
|
article
|
Journal description